Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126831692 | 12683169 | 2 | F | 2016 | 20160825 | 20160825 | 20160831 | EXP | PHHY2016CA101574 | NOVARTIS | 64.87 | YR | M | Y | 0.00000 | 20160831 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126831692 | 12683169 | 1 | PS | COSENTYX | SECUKINUMAB | 1 | Subcutaneous | 300 MG, QMO | 125504 | 300 | MG | INJECTION | /month | ||||||
| 126831692 | 12683169 | 2 | SS | COSENTYX | SECUKINUMAB | 1 | 125504 | INJECTION | |||||||||||
| 126831692 | 12683169 | 3 | SS | VOLTAREN | DICLOFENAC SODIUM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126831692 | 12683169 | 1 | Psoriasis |
| 126831692 | 12683169 | 2 | Psoriatic arthropathy |
| 126831692 | 12683169 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126831692 | 12683169 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126831692 | 12683169 | Accidental exposure to product | |
| 126831692 | 12683169 | Arthralgia | |
| 126831692 | 12683169 | Asthenia | |
| 126831692 | 12683169 | Bite | |
| 126831692 | 12683169 | Depression | |
| 126831692 | 12683169 | Device malfunction | |
| 126831692 | 12683169 | Drug ineffective | |
| 126831692 | 12683169 | Fatigue | |
| 126831692 | 12683169 | Immunodeficiency | |
| 126831692 | 12683169 | Incorrect dose administered | |
| 126831692 | 12683169 | Injection site haemorrhage | |
| 126831692 | 12683169 | Joint swelling | |
| 126831692 | 12683169 | Malaise | |
| 126831692 | 12683169 | Mood altered | |
| 126831692 | 12683169 | Musculoskeletal pain | |
| 126831692 | 12683169 | Pain | |
| 126831692 | 12683169 | Peripheral arthritis | |
| 126831692 | 12683169 | Pruritus | |
| 126831692 | 12683169 | Rash | |
| 126831692 | 12683169 | Somnolence | |
| 126831692 | 12683169 | Streptococcal infection | |
| 126831692 | 12683169 | Throat irritation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126831692 | 12683169 | 1 | 20160428 | 0 |